< Back To intoDNA

< Back To intoDNA

Archives: Workshops

Mar 14, 2022

PARP Family & ADP-ribosylation meeting

About STRIDE™ DNA Damage Response Functional Assays DNA Damage Detection Assays STRIDE™ to γH2AX Comparison Solutions & Services About us Careers Newsroom Resources Media Kit Contact

About STRIDE™ DNA Damage Response Functional Assays DNA Damage Detection Assays STRIDE™ to γH2AX Comparison Solutions & Services

About us Careers Newsroom Resources

Media Kit Contact

Follow Us on Linkedin

I consent to the processing of my personal data by intoDNA.S.A in order to receive company updates. See Privacy Policy for details.

© 2024 INTODNA S.A.

Privacy Policy Term of Use Design and code by fluostudio

© 2024 INTODNA S.A.

Privacy Policy

Term of Use

Design and code by fluostudio

Interested in compatibility of STRIDE and human in vivo material?

The poster showcases the compelling results of our collaboration with AstraZeneca:

validation of STRIDE in human PBMCs and FFPE tissue sections
applicability of STRIDE across different types of tumours
quantification of both endogenous DNA breaks and of breaks induced by DNA-damaging therapeutics and DNA Damage Response (DDR) inhibitors

Share your email with us and we will deliver the material to your inbox:

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

pr

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

See STRIDE Applied: Receive the Case Study

Share your details with us and we will deliver the case study Development and validation of a customized, functional STRIDE-based assay to measure Mismatch Repair (MMR) pathway activity in cells to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

See STRIDE Applied: Receive the Case Study

Share your details with us and we will deliver the case study Studying the effects of alpha and beta-emitters alone and in combination with a DDR inhibitor in a human cell line model to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

See STRIDE Applied: Receive the Case Study

Share your details with us and we will deliver the case study Studying the MoA of a DDR inhibitor in Patient-Derived Xenograft (PDX) models using STRIDE to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Download the AACR poster launching the novel sSTRIDE-SMUG1 assay

Share your details with us and we will deliver the poster Measuring the activity of SMUG1 DNA glycosylase with a novel sSTRIDE-SMUG1 assay to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Download the AACR poster on the potential of dSTRIDE-HR assays to become predictive biomarkers in breast tumors with HR-deficiencies.

Share your details with us and we will deliver the poster Novel dSTRIDE-HR assays can accurately assess DNA repair defects in human cancers and distinguish HR status of tumors to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Download the whitepaper of STRIDE™ technology highlighting the importance of direct detection of DNA breaks.

Share your details with us and we will deliver the whitepaper to your inbox.

By checking this box, you grant intoDNA S.A. permission to use your personal information for the purposes of accessing the downloadable material and sales outreach. Detailed rules of the data processing are set out in the Privacy Policy.

* - mandatory field

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.